Literature DB >> 2551672

The unique insert of cellular and viral fms protein tyrosine kinase domains is dispensable for enzymatic and transforming activities.

G R Taylor1, M Reedijk, V Rothwell, L Rohrschneider, T Pawson.   

Abstract

The receptors for colony stimulating factor-1 (CSF-1), platelet derived growth factor and the c-kit protein tyrosine kinase (PTK) contain within their catalytic domains a stretch of 60-100 residues, largely unrelated in sequence, with no counterpart in other PTKs. Of the 64 amino acids within this kinase insert, 58 were deleted from the mouse CSF-1 receptor by oligonucleotide-directed mutagenesis. The mutant CSF-1 receptor was not markedly affected in its kinase activity, post-translational processing or its ability to induce autocrine transformation of NIH 3T3 mouse fibroblasts. Similarly, retention of kinase and transforming activities were observed following deletion of part or all of the kinase insert from the v-fms oncoprotein. The c- and v-fms kinase inserts were probed using monoclonal and polyclonal antibodies and were found to be highly antigenic. Two monoclonal antibodies raised to the v-fms cytoplasmic domain both recognized epitopes within the insert, and bound enzymatically active v-fms glycoproteins. These results indicate that the fms kinase insert is located on the surface of the protein and folds separately from the rest of the catalytic domain, but is not required for the biological activity of fms PTKs ectopically expressed in mouse fibroblasts. The insert may therefore play a specific function in cells such as monocytes and trophoblasts that normally express the CSF-1 receptor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2551672      PMCID: PMC401083          DOI: 10.1002/j.1460-2075.1989.tb03611.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  43 in total

1.  Identification of aspartate-184 as an essential residue in the catalytic subunit of cAMP-dependent protein kinase.

Authors:  J A Buechler; S S Taylor
Journal:  Biochemistry       Date:  1988-09-20       Impact factor: 3.162

2.  Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype.

Authors:  J Woolford; A McAuliffe; L R Rohrschneider
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

3.  A PDGF receptor domain essential for mitogenesis but not for many other responses to PDGF.

Authors:  J A Escobedo; L T Williams
Journal:  Nature       Date:  1988-09-01       Impact factor: 49.962

4.  Mutational analysis of a phosphotransfer motif essential for v-fps tyrosine kinase activity.

Authors:  M F Moran; C A Koch; I Sadowski; T Pawson
Journal:  Oncogene       Date:  1988-12       Impact factor: 9.867

5.  Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy.

Authors:  R J Tushinski; I T Oliver; L J Guilbert; P W Tynan; J R Warner; E R Stanley
Journal:  Cell       Date:  1982-01       Impact factor: 41.582

6.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

7.  Colony stimulating factor-1 induced growth stimulation of v-fms transformed fibroblasts.

Authors:  S D Lyman; L Park; L R Rohrschneider
Journal:  Oncogene       Date:  1988-10       Impact factor: 9.867

8.  The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus.

Authors:  B Chabot; D A Stephenson; V M Chapman; P Besmer; A Bernstein
Journal:  Nature       Date:  1988-09-01       Impact factor: 49.962

9.  A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential.

Authors:  M F Roussel; J R Downing; C W Rettenmier; C J Sherr
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

10.  A lysine in the ATP-binding site of P130gag-fps is essential for protein-tyrosine kinase activity.

Authors:  G Weinmaster; M J Zoller; T Pawson
Journal:  EMBO J       Date:  1986-01       Impact factor: 11.598

View more
  24 in total

1.  Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects.

Authors:  Vinciane Wouters; Nisha Limaye; Melanie Uebelhoer; Alexandre Irrthum; Laurence M Boon; John B Mulliken; Odile Enjolras; Eulalia Baselga; Jonathan Berg; Anne Dompmartin; Sten A Ivarsson; Loshan Kangesu; Yves Lacassie; Jill Murphy; Ahmad S Teebi; Anthony Penington; Paul Rieu; Miikka Vikkula
Journal:  Eur J Hum Genet       Date:  2009-11-04       Impact factor: 4.246

2.  Influence of tyrosine residues Y705 and Y807 on the transforming potency of the v-fms oncogene product of feline sarcoma virus.

Authors:  S Trouliaris; A Hadwiger-Fangmeier; M Heimann; T Tamura
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

3.  The amino terminus of polyomavirus middle T antigen is required for transformation.

Authors:  D N Cook; J A Hassell
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

4.  Deletion of the kinase insert sequence of the platelet-derived growth factor beta-receptor affects receptor kinase activity and signal transduction.

Authors:  L Severinsson; B Ek; K Mellström; L Claesson-Welsh; C H Heldin
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

5.  The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors.

Authors:  S Roche; M Koegl; S A Courtneidge
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

6.  Interactions of phosphatidylinositol kinase, GTPase-activating protein (GAP), and GAP-associated proteins with the colony-stimulating factor 1 receptor.

Authors:  M Reedijk; X Q Liu; T Pawson
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

7.  Induction of macrophage colony-stimulating factor-dependent growth and differentiation after introduction of the murine c-fms gene into FDC-P1 cells.

Authors:  L R Rohrschneider; D Metcalf
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

8.  Delineation of functional determinants in the transforming protein of Fujinami sarcoma virus.

Authors:  K A Johnson; J C Stone
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

9.  Phosphatidylcholine hydrolysis and c-myc expression are in collaborating mitogenic pathways activated by colony-stimulating factor 1.

Authors:  X X Xu; T G Tessner; C O Rock; S Jackowski
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

10.  Tyrosine 706 and 807 phosphorylation site mutants in the murine colony-stimulating factor-1 receptor are unaffected in their ability to bind or phosphorylate phosphatidylinositol-3 kinase but show differential defects in their ability to induce early response gene transcription.

Authors:  P van der Geer; T Hunter
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.